Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency
2002
In summary, this study suggests that the use of abciximab in patients with chronic renal dysfunction undergoing PCI is relatively safe and not associated with an increased risk of major bleeding.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
15
References
25
Citations
NaN
KQI